Form D · Biotechnology

Purinomia Biotech, Inc.

Woburn, MA · CIK 0001723458

Offering snapshot reported Jun 7, 2024 · SEC filing

Reported sold
$1M
Offering amount: $2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 24, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 7, 2024Initial$1,000,000No comparison1SEC filing
Nov 7, 2023Initial$1,000,000No comparison1SEC filing
Apr 21, 2023Initial$500,000No comparison1SEC filing
Jan 6, 2023Initial$1,500,000No comparison1SEC filing
Jan 5, 2022Initial$1,300,000No comparison2SEC filing
Feb 22, 2021Initial$1,999,998No comparison1SEC filing
May 22, 2020Initial$2,828,251No comparison3SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-515423

Source: Form D, filed Jun 7, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Shaoyong Hu Director
Qianye Karen Liu Director
Simon C. Robson Director
Yan Wu Shang Director, Executive
Zhe Wang Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2 E Gill Street
Woburn, MA, 01801